Clinical Trial Update: Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis [Phase 4]

View source ↗

Summary

Phase 4 trial update on prevention of relapses in PR3-ANCA-associated vasculitis; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasculitis

Snippet

Sponsor: University Medical Center Groningen | Conditions: Vasculitis | Phase 4 | Status: TERMINATED